Session Abstract
This presentation describes the systematic approach taken by Pfizer to identify, evaluate, and implement the company’s next generation bioreactor control system. A five year timeline of events and three distinct phases will be highlighted: Technology Evaluation, Technology Maturation, and Technology Deployment. Challenges and solutions for each phase will also be shared. The result is a bioreactor control system that drives efficiency in the PD laboratories, increases data capture capability reinforcing process development towards Quality by Design, and provides a flexible structure to integrate emerging bioprocess technologies.
Speakers:
George S. Moyer
Broadley-James Corporation
Irvine, CA USA
Company:
Broadley-James Corporation